StonvexLoading…
StonvexStonvexStonvexCore line items from CNMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $344.24M | $1.37B | $1.00B | $663.60M | $321.26M |
Operating Income | Not available | $102.62M | $66.00M | $54.12M | $15.96M |
Net Income | Not available | $47.05M | $30.32M | $27.46M | $6.04M |
EPS (Diluted) | $1.13 | $1.51 | $0.97 | $0.88 | $0.19 |
Total Assets | Not available | $2.33B | $2.32B | $2.33B | $2.30B |
Total Liabilities | Not available | $1.29B | $1.31B | $1.33B | $1.32B |
Cash & Equivalents | Not available | $40.82M | $38.93M | $33.94M | $35.48M |
Free Cash Flow OCF − CapEx | Not available | $150.88M | $109.66M | $61.16M | $37.76M |
Shares Outstanding | Not available | 31.15M | 31.14M | 31.14M | 31.15M |